Both in Pharmaceuticals
Rigel Pharmaceuticals Inc. (New) vs MoonLake Immunotherapeutics
Over the past year RIGL returned +67.8% and MLTX returned +11.8%; their daily moves had a correlation of 0.15.
RIGL +67.8% MLTX +11.8%Growth of $1, one year, split-adjusted
| Metric | RIGL | MLTX |
|---|---|---|
| Price | $51.44 | $11.40 |
| Market cap | $960.8M | $970.2M |
| Today | +5.27% | −2.56% |
| 1 month | +11.5% | +4.1% |
| 6 months | +92.9% | −35.6% |
| Year to date | +20.1% | −13.5% |
| 1 year | +67.8% | +11.8% |
| Revenue growth (YoY) | −22.6% | — |
| Gross margin | 89.2% | — |
| Net margin | 22.0% | — |
| P/E (TTM) | 3.0× | — |
| Price / sales | 3.5× | — |
| Net cash | $56.1M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 37.9% | 57.1% |
| Short % of float | 16.3% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).